However, even during molecular genetic analysis, the potentially pathogenic silent mutations seem to be overlooked not only in CPT II deficiency but in a lot of autosomal disorders. This evidence concerns the gene CPT2 and hyperinsulinemic hypoglycemia, familial, 4.